{"entity":{"type":"insider","cik":"0001430462","url":"/insider/0001430462","json_url":"/insider/0001430462.json","name":"Khayal Tamer I","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":141,"n_filings":44,"first":"2020-01-22","last":"2025-03-05","span_basis":"filed_date"},"name_variants":[{"name":"Khayal Tamer I","source":"filing","n_filings":44,"first_seen":"2020-01-22","last_seen":"2025-03-05"}],"transactions":[{"id":4059451,"accession":"0000950170-25-033706","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-033706","line_url":"/filing/0000950170-25-033706#line-1","is_derivative":false,"issuer_cik":"0001430462","issuer_name":"TransMedics Group, Inc.","issuer_ticker":"TMDX","issuer_name_source":null,"issuer_url":"/issuer/0001430462","owner_cik":"0001430462","owner_name":"Khayal Tamer I","owner_display_name":"Khayal Tamer I","owner_url":"/insider/0001430462","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2407.0,"shares_display":"2,407","price_per_share":76.43,"price_display":"76.43","price_state":"stated","total_value":183967.01,"total_display":"183,967.01","total_whole":"183,967","shares_owned_after":36042.0,"shares_owned_after_display":"36,042","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-03","filed_date":"2025-03-05","scope":"insider"},{"id":5068160,"accession":"0000950170-25-004192","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-004192","line_url":"/filing/0000950170-25-004192#line-2","is_derivative":false,"issuer_cik":"0001430462","issuer_name":"TransMedics Group, Inc.","issuer_ticker":"TMDX","issuer_name_source":null,"issuer_url":"/issuer/0001430462","owner_cik":"0001430462","owner_name":"Khayal Tamer I","owner_display_name":"Khayal Tamer I","owner_url":"/insider/0001430462","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1083.0,"shares_display":"1,083","price_per_share":80.05,"price_display":"80.05","price_state":"stated","total_value":86694.15,"total_display":"86,694.15","total_whole":"86,694","shares_owned_after":20843.0,"shares_owned_after_display":"20,843","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-07","filed_date":"2025-01-10","scope":"insider"},{"id":2681358,"accession":"0000950170-24-133392","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-133392","line_url":"/filing/0000950170-24-133392#line-2","is_derivative":false,"issuer_cik":"0001430462","issuer_name":"TransMedics Group, Inc.","issuer_ticker":"TMDX","issuer_name_source":null,"issuer_url":"/issuer/0001430462","owner_cik":"0001430462","owner_name":"Khayal Tamer I","owner_display_name":"Khayal Tamer I","owner_url":"/insider/0001430462","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1084.0,"shares_display":"1,084","price_per_share":86.4,"price_display":"86.40","price_state":"stated","total_value":93657.6,"total_display":"93,657.60","total_whole":"93,658","shares_owned_after":20843.0,"shares_owned_after_display":"20,843","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-02","filed_date":"2024-12-04","scope":"insider"},{"id":2277850,"accession":"0000950170-24-126397","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-126397","line_url":"/filing/0000950170-24-126397#line-2","is_derivative":false,"issuer_cik":"0001430462","issuer_name":"TransMedics Group, Inc.","issuer_ticker":"TMDX","issuer_name_source":null,"issuer_url":"/issuer/0001430462","owner_cik":"0001430462","owner_name":"Khayal Tamer I","owner_display_name":"Khayal Tamer I","owner_url":"/insider/0001430462","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1458.0,"shares_display":"1,458","price_per_share":90.04,"price_display":"90.04","price_state":"stated","total_value":131278.32,"total_display":"131,278.32","total_whole":"131,278","shares_owned_after":20843.0,"shares_owned_after_display":"20,843","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-11","filed_date":"2024-11-13","scope":"insider"},{"id":2903079,"accession":"0000950170-24-121525","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-121525","line_url":"/filing/0000950170-24-121525#line-2","is_derivative":false,"issuer_cik":"0001430462","issuer_name":"TransMedics Group, Inc.","issuer_ticker":"TMDX","issuer_name_source":null,"issuer_url":"/issuer/0001430462","owner_cik":"0001430462","owner_name":"Khayal Tamer I","owner_display_name":"Khayal Tamer I","owner_url":"/insider/0001430462","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1083.0,"shares_display":"1,083","price_per_share":82.64,"price_display":"82.64","price_state":"stated","total_value":89499.12,"total_display":"89,499.12","total_whole":"89,499","shares_owned_after":20843.0,"shares_owned_after_display":"20,843","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-01","filed_date":"2024-11-05","scope":"insider"},{"id":2650910,"accession":"0000950170-24-112394","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0000950170-24-112394","line_url":"/filing/0000950170-24-112394","is_derivative":false,"issuer_cik":"0001430462","issuer_name":"TransMedics Group, Inc.","issuer_ticker":"TMDX","issuer_name_source":null,"issuer_url":"/issuer/0001430462","owner_cik":"0001430462","owner_name":"Khayal Tamer I","owner_display_name":"Khayal Tamer I","owner_url":"/insider/0001430462","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2958.0,"shares_display":"2,958","price_per_share":148.23897903989183,"price_display":"148.24","price_state":"stated","total_value":438490.9,"total_display":"438,490.90","total_whole":"438,491","shares_owned_after":22078.0,"shares_owned_after_display":"22,078","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-01","filed_date":"2024-10-03","scope":"insider","n_lines":9},{"id":2418561,"accession":"0000950170-24-104046","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0000950170-24-104046","line_url":"/filing/0000950170-24-104046","is_derivative":false,"issuer_cik":"0001430462","issuer_name":"TransMedics Group, Inc.","issuer_ticker":"TMDX","issuer_name_source":null,"issuer_url":"/issuer/0001430462","owner_cik":"0001430462","owner_name":"Khayal Tamer I","owner_display_name":"Khayal Tamer I","owner_url":"/insider/0001430462","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2960.0,"shares_display":"2,960","price_per_share":159.59579054054055,"price_display":"159.60","price_state":"stated","total_value":472403.54,"total_display":"472,403.54","total_whole":"472,404","shares_owned_after":22283.0,"shares_owned_after_display":"22,283","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-03","filed_date":"2024-09-05","scope":"insider","n_lines":8},{"id":2679187,"accession":"0000950170-24-091017","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0000950170-24-091017","line_url":"/filing/0000950170-24-091017","is_derivative":false,"issuer_cik":"0001430462","issuer_name":"TransMedics Group, Inc.","issuer_ticker":"TMDX","issuer_name_source":null,"issuer_url":"/issuer/0001430462","owner_cik":"0001430462","owner_name":"Khayal Tamer I","owner_display_name":"Khayal Tamer I","owner_url":"/insider/0001430462","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2958.0,"shares_display":"2,958","price_per_share":156.7705104800541,"price_display":"156.77","price_state":"stated","total_value":463727.17,"total_display":"463,727.17","total_whole":"463,727","shares_owned_after":22540.0,"shares_owned_after_display":"22,540","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-01","filed_date":"2024-08-05","scope":"insider","n_lines":14},{"id":2985459,"accession":"0000950170-24-081567","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000950170-24-081567","line_url":"/filing/0000950170-24-081567","is_derivative":false,"issuer_cik":"0001430462","issuer_name":"TransMedics Group, Inc.","issuer_ticker":"TMDX","issuer_name_source":null,"issuer_url":"/issuer/0001430462","owner_cik":"0001430462","owner_name":"Khayal Tamer I","owner_display_name":"Khayal Tamer I","owner_url":"/insider/0001430462","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2958.0,"shares_display":"2,958","price_per_share":151.40396889790398,"price_display":"151.40","price_state":"stated","total_value":447852.94,"total_display":"447,852.94","total_whole":"447,853","shares_owned_after":21585.0,"shares_owned_after_display":"21,585","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-01","filed_date":"2024-07-03","scope":"insider","n_lines":5},{"id":2142079,"accession":"0000950170-24-069423","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0000950170-24-069423","line_url":"/filing/0000950170-24-069423","is_derivative":false,"issuer_cik":"0001430462","issuer_name":"TransMedics Group, Inc.","issuer_ticker":"TMDX","issuer_name_source":null,"issuer_url":"/issuer/0001430462","owner_cik":"0001430462","owner_name":"Khayal Tamer I","owner_display_name":"Khayal Tamer I","owner_url":"/insider/0001430462","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2960.0,"shares_display":"2,960","price_per_share":133.10336148648648,"price_display":"133.10","price_state":"stated","total_value":393985.95,"total_display":"393,985.95","total_whole":"393,986","shares_owned_after":22019.0,"shares_owned_after_display":"22,019","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-03","filed_date":"2024-06-05","scope":"insider","n_lines":7},{"id":2387975,"accession":"0000950170-24-055795","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-055795","line_url":"/filing/0000950170-24-055795#line-2","is_derivative":false,"issuer_cik":"0001430462","issuer_name":"TransMedics Group, Inc.","issuer_ticker":"TMDX","issuer_name_source":null,"issuer_url":"/issuer/0001430462","owner_cik":"0001430462","owner_name":"Khayal Tamer I","owner_display_name":"Khayal Tamer I","owner_url":"/insider/0001430462","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5839.0,"shares_display":"5,839","price_per_share":130.07,"price_display":"130.07","price_state":"stated","total_value":759478.73,"total_display":"759,478.73","total_whole":"759,479","shares_owned_after":9792.0,"shares_owned_after_display":"9,792","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-06","filed_date":"2024-05-08","scope":"insider"},{"id":9213019,"accession":"0000950170-24-059829","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0000950170-24-059829","line_url":"/filing/0000950170-24-059829#line-14","is_derivative":false,"issuer_cik":"0001430462","issuer_name":"TransMedics Group, Inc.","issuer_ticker":"TMDX","issuer_name_source":null,"issuer_url":"/issuer/0001430462","owner_cik":"0001430462","owner_name":"Khayal Tamer I","owner_display_name":"Khayal Tamer I","owner_url":"/insider/0001430462","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11051.0,"shares_display":"11,051","price_per_share":105.71,"price_display":"105.71","price_state":"stated","total_value":1168201.21,"total_display":"1,168,201.21","total_whole":"1,168,201","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-05-01","filed_date":"2024-05-14","scope":"insider"}],"collapsed":true,"next_cursor":"2024-05-01|9213019","ledger_fault":false,"count":{"value":141,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":141,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":141},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001756262","name":"TransMedics Group, Inc.","url":"/issuer/0001756262","role":"Officer (Chief Commercial Officer)","n_filings":44,"first_seen":"2020-01-22","last_seen":"2025-03-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001430462","retrieved_at":"2026-08-26T09:23:57+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}